Pelgifatamab
Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody. Pelgifatamab can be covalently linked to a binding moiety of 225Ac and used for metastatic castration-resistant prostate cancer (mCRPC) research[1].
Product Specifications
CAS Number
[2414550-93-7]
Product Name Alternative
BAY-2315497; PSMA-TTC
UNSPSC
12352203
Target
PSMA
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pelgifatamab.html
Purity
99.884
Solubility
H2O
Smiles
[Pelgifatamab]
Molecular Weight
(146.24 kDa)
References & Citations
[1]Pelgifatamab
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
